Litcius/Paper detail

Antiviral Response Induced by Toll-Like Receptor (TLR) 7/TLR8 Activation Inhibits Human Immunodeficiency Virus Type 1 Infection in Cord Blood Macrophages

Anna Julia Pietrobon, Fábio Seiti Yamada Yoshikawa, Luana Mendonça de Oliveira, Nátalli Zanete Pereira, Taís Matozo, Bruna Cunha de Alencar, Alberto J. S. Duarte, Maria Notomi Sato

2021The Journal of Infectious Diseases11 citationsDOI

Abstract

Vertical transmission is the main mechanism of human immunodeficiency virus type 1 (HIV-1) infection in infants, who may develop high viremia and rapidly progress to AIDS. Innate immunity agonists can control HIV-1 replication in vitro, but the protective effect in the neonatal period remains unknown. Herein, we evaluated the immunomodulatory and antiviral effects of type I interferon (IFN-I) adjuvants on cord blood monocyte-derived macrophages upon HIV-1 infection. Despite the phenotypic and transcriptional similarities between cord blood and adult macrophages, cord blood cells were prone to viral replication when infected with HIV-1. However, treatment with CL097 efficiently promoted the antiviral and inflammatory responses and inhibited HIV-1 replication in cord blood cells in an NF-κB and autophagy activation-independent manner. Our data suggest that cord blood macrophages are able to establish antiviral responses induced by IFN-I adjuvants similar to those of their adult counterparts, revealing a potential adjuvant candidate to enhance the neonatal immune response.

Topics & Concepts

ViremiaImmunologyCord bloodBiologyVirusVirologyImmune systemInnate immune systemViral replicationAdjuvantUmbilical cordImmunityInterferonHIV Research and TreatmentImmune Cell Function and InteractionCytomegalovirus and herpesvirus research
Antiviral Response Induced by Toll-Like Receptor (TLR) 7/TLR8 Activation Inhibits Human Immunodeficiency Virus Type 1 Infection in Cord Blood Macrophages | Litcius